High-dose vitamins and minerals offer no benefit for recurrent 'cardiac events'

- Last updated on GMT

High-dose vitamins, minerals no benefit for recurrent cardiac events
Supplementation with vitamins and minerals does not help to reduce recurrences of cardiac events in people who have suffered a heart attack, says research.

The new study data, which is as yet unpublished but was presented at the American College of Cardiology's 62nd Annual Scientific Session, suggests that heart attack patients who are given a combination of high-dose oral vitamins and minerals do not show significant reductions in recurrent cardiac events.

The results comes from the NIH-funded Trial to Assess Chelation Therapy (TACT) study, for which previous results have shown that when combined with active chelation therapy, such high-dose supplements can offer additional benefits.

"We did not see a significant benefit of vitamins alone for patients who had a heart attack​," said lead author of the study Dr Gervasio Lamas, from Columbia University Mount Sinai Medical Center.

"Interestingly, patients who received both high dose vitamins and active chelation compared to placebo of both appeared to have additional benefit,"​ he said, noting that more research is required to understand why vitamin and mineral supplements offer no benefit on their own but do offer additional benefits when coupled with chelation.

Study details

The TACT study tested the safety and effectiveness of both EDTA chelation therapy and high-dose vitamin and mineral supplements in a group of 1,708 individuals with prior heart attacks.

The participants were split to receive one of four patterns of treatment: active chelation plus active oral vitamins, active chelation plus placebo oral vitamins, placebo chelation plus active oral vitamins, or placebo chelation plus placebo oral vitamins.

Since 1956, alternative medicine practitioners have used EDTA chelation to treat cardiovascular disease.

Chelation therapy involves multiple intravenous infusions of a synthetic amino acid called EDTA, which binds to certain minerals and metals, including calcium, lead and cadmium. The practice has been used as a way to treat cardiovascular disease by some alternative therapists.

Lamas and his colleagues, said that this 2 x 2 factorial design allowed them to clarify the independent contributions of each treatment.

Over the four years of follow-up, the active/active arm had 108 (26%) events and the placebo/placebo arm had 139 (32%) events—a statistically significant difference.

Related news

Show more

Related products

show more

Vitamin K2 Success Stories: NattoPharma

Vitamin K2 Success Stories: NattoPharma

NattoPharma USA, Inc. | 23-Sep-2019 | Case Study

Partnership means companies are bound to the process – from formulation and testing to marketing and meeting demand. That is what companies selecting MenaQ7®...

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals | 01-Sep-2019 | Application Note

The industry has shown improvement in its transparency in the past 5 years. Per the regulations, a Brand Owner is 100% responsible for the quality of...

Related suppliers

2 comments

High dose vitamins and synthetic amino-acid ?

Posted by harry,

Only non synthetic nutrition can achieve higher benefits over time.

Report abuse

Vitamins

Posted by Anne,

They prob. used the wrong type of Vitamins

Report abuse

Follow us

Featured Events

View more

Products

View more

Webinars